Maternal and Infant Factors Predicting Disease Progression in Human Immunodeficiency Virus Type 1-Infected Infants
Kenneth Rich(University of Illinois Chicago), I. Celine Hanson(Baylor College of Medicine), Lynne Mofenson(Elizabeth Glaser Pediatric AIDS Foundation), Mary Glenn Fowler(Johns Hopkins University), Clemente Díaz(University of Puerto Rico System), Jane Pitt(National Institute of Allergy and Infectious Diseases), Hermann Mendez(State University of New York), Rasha Abboud(University of Illinois Chicago), Ellen Cooper(Boston University)
Cited by 97
Related Papers
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
|The Lancet|1999|1.7k
Combination Antiretroviral Strategies for the Treatment of Pregnant HIV-1–Infected Women and Prevention of Perinatal HIV-1 Transmission
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2002|896
Combination Antiretroviral Strategies for the Treatment of Pregnant HIV-1–Infected Women and Prevention of Perinatal HIV-1 Transmission
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2002|697
Measles Antibody: Reevaluation of Protective Titers
|The Journal of Infectious Diseases|1990|612